# Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

> **NCT06538311** · EARLY_PHASE1 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Logopenic Progressive Aphasia
- Amnestic Symptoms

## Interventions

- **DEVICE:** Active rTMS
- **DEVICE:** Sham rTMS

## Key facts

- **NCT ID:** NCT06538311
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06538311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06538311, "Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06538311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*